Top Markets
Coin of the day
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rang in aandelen #7326
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Aandeelprijs
$36.75
Laatst gesynchroniseerd: 2026-08-27
Marktkapitalisatie
$1.63B
Verandering (1 dag)
-0.78%
Verandering (1 jaar)
-
Land
US
Handel Avalyn Pharma Inc. Common Stock (AVLN)

Categorie

Koersgeschiedenis voor Avalyn Pharma Inc. Common Stock (AVLN)
Hoogste slotkoers: $36.94 op 2026-08-01

Laagste slotkoers: $29.49 op 2026-04-01
Koersgeschiedenis van Avalyn Pharma Inc. Common Stock van 2026 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
Niet genoeg gegevens voor de verstrekte datums.
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$762.91 7.41%
CH